Editor’s observe: A livestream of the dialog might be embedded under at 1 p.m. ET.
Every week, STAT+ subscribers get entry to unique conversations with biotech, pharma, and well being tech leaders. This week, STAT common task reporter and affiliate editorial director of occasions Nicholas St. Fleur might be joined by Andrew Joseph, common task reporter at STAT. They are going to be discussing the Delta variant, breakthrough instances, challenges it poses to ending the pandemic, new CDC steerage, and naturally be taking your questions dwell.
Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!
GET STARTED
What’s it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, coverage, and life science protection and evaluation.
Our award-winning staff covers information on Wall Avenue, coverage developments in Washington, early science breakthroughs and medical trial outcomes, and well being care disruption in Silicon Valley and past.
What’s included?
- Day by day reporting and evaluation
- Probably the most complete business protection from a powerhouse staff of reporters
- Subscriber-only newsletters
- Day by day newsletters to temporary you on crucial business information of the day
- STAT+ Conversations
- Weekly alternatives to interact with our reporters and main business specialists in dwell video conversations
- Unique business occasions
- Premium entry to subscriber-only networking occasions across the nation
- The most effective reporters within the business
- Probably the most trusted and well-connected newsroom within the well being care business
- And rather more
- Unique interviews with business leaders, profiles, and premium instruments, like our CRISPR Trackr.